A detailed history of Iron Financial, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Iron Financial, LLC holds 13,530 shares of BMY stock, worth $547,288. This represents 0.41% of its overall portfolio holdings.

Number of Shares
13,530
Previous 10,470 29.23%
Holding current value
$547,288
Previous $537,000 36.5%
% of portfolio
0.41%
Previous 0.3%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$47.98 - $54.4 $146,818 - $166,464
3,060 Added 29.23%
13,530 $733,000
Q4 2023

Jan 19, 2024

SELL
$48.48 - $57.85 $24,676 - $29,445
-509 Reduced 4.64%
10,470 $537,000
Q3 2023

Oct 31, 2023

BUY
$57.89 - $64.73 $53,606 - $59,939
926 Added 9.21%
10,979 $637,000
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $4,459 - $4,951
-70 Reduced 0.69%
10,053 $642,000
Q1 2023

Apr 25, 2023

BUY
$65.71 - $74.53 $665,182 - $754,467
10,123 New
10,123 $701,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Iron Financial, LLC Portfolio

Follow Iron Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iron Financial, LLC with notifications on news.